WMT AG
PrivateLast Round
VC Round
Oct 14, 2025
Total Funding Raised
$2.22M
Momentum Score
25 /100
Company Overview
WMT AG is a biotechnology company that develops small molecule therapeutics for the treatment of cancer and inflammatory diseases.
Historical Pricing
Historical view of private secondary pricing and transaction trends.
WMT AG Comps
Public and private peers based on sector, stage, and business model.
WMT AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Oct 14, 2025 | ||||
| VC Round | Jan 23, 2025 | ||||
| VC Round | Nov 28, 2023 |
WMT AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| FS Life Science Investment | VC Round |
| Viva Biotech | Seed |
| Marathon Beteiligungs AG | VC Round |
| CARMA FUND | VC Round |
| High-Tech Gründerfonds | VC Round, Seed |
| L-Bank | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 15, 2025
Grew 21% QoQ from 14 to 17 employees.
- Oct 14, 2025
$4.25M round led by Marathon Beteiligungs AG
WMT AG Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about WMT AG's valuation, stock price, and market status.
Firmographic Details
HeadquartersHeidelberg
Employee Range17
Year Founded2020
Last FundingOct 14, 2025